SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Morgan Stanley Maintains Overweight on Moderna, Raises Price Target to $90

Morgan Stanley maintains Moderna (NASDAQ:MRNA) with a Overweight and raises the price target from $37 to $90.

Benzinga · 05/20/2020 12:16

Morgan Stanley maintains Moderna (NASDAQ:MRNA) with a Overweight and raises the price target from $37 to $90.